BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellceutix 

100 Cumming Center, Suite 151-B
Suite A225
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-236-8717 Fax: 978-921-6564


SEARCH JOBS










 Company News
Cellceutix (CTIX) To Expand Its Skin Product Pipeline 3/3/2015 9:42:39 AM
Cellceutix (CTIX) Enthusiastic About Proposed Budget Increase To $1.2 Billion To Fight Drug-Resistance Bacteria 1/28/2015 12:31:43 PM
Cellceutix (CTIX) Plans Clinical Trial In Patients With Ulcerative Proctitis 1/26/2015 11:00:33 AM
Cellceutix (CTIX) Phase 2b Clinical Trial Of Brilacidin Accepted For Oral Presentation At The European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID) 1/22/2015 11:24:32 AM
Cellceutix (CTIX) Reports Spleen Lesion "Disappears" In Patient With Metastatic Stage 4 Ovarian Cancer In Clinical Trial Of Anti-Cancer Drug Kevetrin 1/20/2015 11:21:49 AM
Cellceutix (CTIX) Invites All To Attend Company's Live Webcast Of Presentation At Biotech Showcase 2015 Today At 2:00 PM PT (5:00 PM ET) 1/13/2015 1:22:33 PM
Cellceutix (CTIX) Releases Confidence Interval Statistics Showing Clinical Success Rates For Brilacidin In Treatment Of ABSSSI 1/5/2015 8:59:08 AM
Cellceutix (CTIX) Adds Dr. Daniel Jorgensen As Chief Medical Officer 12/29/2014 10:13:15 AM
Cellceutix (CTIX) Reports Positive Results Of Brilacidin In Microbiological Intent-To-Treat Population In Phase 2b ABSSSI Trial; Additional Pharmacokinetic Information To Be Submitted 12/23/2014 9:37:59 AM
Cellceutix (CTIX): Prurisol™ For Psoriasis -- FDA Agrees That Phase 2 Study May Begin 12/11/2014 8:15:26 AM
12345678910...